Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Elemental sulfur or compound thereof
Reexamination Certificate
2011-08-09
2011-08-09
Richter, Johann R (Department: 1616)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Elemental sulfur or compound thereof
C435S001100
Reexamination Certificate
active
07993681
ABSTRACT:
The present invention concerns the use of oxygen antagonists for inducing stasis in tissue, including all or part of organs. It includes methods and apparatuses for achieving stasis in tissue, so as to preserve and/or protect them. In specific embodiments, preservation methods and apparatuses for preserving tissue for transplantation purposes is provided.
REFERENCES:
patent: 1379855 (1921-05-01), Donner
patent: 2031489 (1936-02-01), Koenigsberger
patent: 2435854 (1948-02-01), Taylor
patent: 2487558 (1949-11-01), Kamlet
patent: 3587899 (1971-06-01), Bender et al.
patent: 4186565 (1980-02-01), Toledo-Pereyra
patent: 4502295 (1985-03-01), Toledo-Pereyra
patent: 4798824 (1989-01-01), Belzer et al.
patent: 4807442 (1989-02-01), Linner et al.
patent: 4920044 (1990-04-01), Bretan, Jr.
patent: 4923442 (1990-05-01), Segall et al.
patent: 4938961 (1990-07-01), Collins et al.
patent: 4951482 (1990-08-01), Gilbert
patent: 5066578 (1991-11-01), Wikman-Coffelt
patent: 5157930 (1992-10-01), McGhee et al.
patent: 5173088 (1992-12-01), Maeda et al.
patent: 5285657 (1994-02-01), Bacchi et al.
patent: 5326706 (1994-07-01), Yland et al.
patent: 5328821 (1994-07-01), Fisher et al.
patent: 5370989 (1994-12-01), Stern et al.
patent: 5395314 (1995-03-01), Klatz et al.
patent: 5405742 (1995-04-01), Taylor
patent: 5464768 (1995-11-01), Kiel et al.
patent: 5476764 (1995-12-01), Bitensky
patent: 5552267 (1996-09-01), Stern et al.
patent: 5569579 (1996-10-01), Murphy
patent: 5599659 (1997-02-01), Brasile et al.
patent: 5693462 (1997-12-01), Raymond
patent: 5699793 (1997-12-01), Brasile
patent: 5719174 (1998-02-01), Sainsbury et al.
patent: 5736397 (1998-04-01), Garcia et al.
patent: 5752929 (1998-05-01), Klatz et al.
patent: 5770583 (1998-06-01), Haslwanter et al.
patent: 5791151 (1998-08-01), Verhaag et al.
patent: 5912019 (1999-06-01), Singh
patent: 5948392 (1999-09-01), Haslwanter et al.
patent: 6013256 (2000-01-01), Light et al.
patent: 6046046 (2000-04-01), Hassanein
patent: 6054261 (2000-04-01), Masterson
patent: 6100082 (2000-08-01), Hassanein
patent: 6109260 (2000-08-01), Bathe
patent: 6164276 (2000-12-01), Bathe et al.
patent: 6365338 (2002-04-01), Bull et al.
patent: 6490880 (2002-12-01), Walsh
patent: 6492103 (2002-12-01), Taylor
patent: 6524785 (2003-02-01), Cozzone et al.
patent: 6552083 (2003-04-01), Isobe et al.
patent: 6557492 (2003-05-01), Robohm
patent: 6602277 (2003-08-01), Grahn et al.
patent: 6857443 (2005-02-01), Volgyesi
patent: 6962154 (2005-11-01), Krebs
patent: 7045140 (2006-05-01), Motterlini et al.
patent: 2002/0068265 (2002-06-01), Lopez et al.
patent: 2002/0155166 (2002-10-01), Choi et al.
patent: 2003/0050227 (2003-03-01), Kondo
patent: 2003/0176317 (2003-09-01), Guenzler-Pukall et al.
patent: 2003/0235571 (2003-12-01), Gojon-Romanillos
patent: 2004/0109903 (2004-06-01), Shaklai et al.
patent: 2004/0254215 (2004-12-01), Arend et al.
patent: 2005/0136125 (2005-06-01), Roth
patent: 2005/0147692 (2005-07-01), Roth
patent: 2005/0170019 (2005-08-01), Roth
patent: 2005/0217667 (2005-10-01), Dhuper
patent: 2005/0227948 (2005-10-01), Schofield et al.
patent: 2006/0003972 (2006-01-01), Wallace et al.
patent: 2006/0270635 (2006-11-01), Wallace et al.
patent: 2007/0078113 (2007-04-01), Roth et al.
patent: 2008/0085329 (2008-04-01), Roth et al.
patent: 2008/0171726 (2008-07-01), Roth et al.
patent: 0 073 590 (1982-01-01), None
patent: 0 061 277 (1982-03-01), None
patent: 0 158 728 (1984-12-01), None
patent: 0153215 (1985-08-01), None
patent: 0203730 (1986-12-01), None
patent: 0681558 (1993-11-01), None
patent: 1395241 (2004-03-01), None
patent: 2816212 (2002-05-01), None
patent: WO 84/01292 (1984-04-01), None
patent: WO 91/01638 (1991-02-01), None
patent: WO 94/16991 (1994-08-01), None
patent: WO 94/17178 (1994-08-01), None
patent: WO 96/02461 (1996-02-01), None
patent: WO 98/13058 (1998-04-01), None
patent: WO 01/81546 (2001-11-01), None
patent: WO 01/92874 (2001-12-01), None
patent: WO 02/09514 (2002-02-01), None
patent: WO 02/101018 (2002-12-01), None
patent: WO 03/072024 (2003-09-01), None
patent: WO 03/088981 (2003-10-01), None
patent: WO 04/043341 (2004-05-01), None
patent: WO 2004/060147 (2004-07-01), None
patent: WO 2005/039291 (2005-05-01), None
patent: WO 2005/041655 (2005-05-01), None
patent: WO 2005/041656 (2005-05-01), None
patent: WO 2005/046595 (2005-05-01), None
patent: WO 2005/115075 (2005-12-01), None
patent: WO 2006/085127 (2006-08-01), None
patent: WO 2006/102536 (2006-09-01), None
patent: WO 2006/119258 (2006-11-01), None
Brown, Biochimica et Biophysica Acta, 2001,1504, 46-57.
Brown et al., Biochem. J., 1996, 315, 295-299.
Leslie, Science, 2008, 320, 1155-1157.
Eghbal et al., “H2S cytotoxicity mechanism involves reactive oxygen species formation and mitochondial depolarisation,”Toxicology, 203:69-76, 2004.
PCT International Search Report and Written Opinion, issued in International Application No. PCT/US2006/015158, dated Jan. 31, 2007.
Anthony et al., Preservation of viable biological samples for experiments in space laboratories,J. of Biotechnology, 45:377-393, 1996.
Database Caplus Chemical Abstract Service. Moser et al. “Octreotide promotes gallbladder absorption om [rairie dogs: a potential cause of gallstones” XPO02319493, STN Accession No. 1995:594873.
Hogman, “How can we improve platelet preparation and storage?”Transfus. Sci., 17:545-551, 1996.
Nystul and Roth, “Carbon monoxide-induced suspended animation protects against hypoxic damage inCaenorhabditis elegans,” The National Academy of the Sciences of the United States of America, 101:9133-9136, 2004.
Roberts et al., “Two sensor kinases contribute to the hypoxic response ofMycobacterium tuberculosis,” J. of Biological Chem., 279:23082-23087, 2004.
Australian Application No. 2004285468, Examination Report dated Jun. 23, 2009.
Bagarinao, “Sulphide Tolerance and Adaption in the California Killifish,Fundulus parvipinnis, a Salt March Resident,”J. Fish Biology, 1993, 42, 729-748.
Yanmoto, “Prolonged Mild Hypothermia Therapy Protects the Brain Against Permanent Focal Ischemia,”Stroke, 2001, 32, 232-239.
United States Patent and Trademark Office: Restriction Requirement dated Jan. 9, 2008, U.S. Appl. No. 10/971,575.
United States Patent and Trademark Office: Non-Final Office Action dated Jun. 19, 2008, U.S. Appl. No. 10/971,575.
United States Patent and Trademark Office: Final Office Action dated Feb. 24, 2009, U.S. Appl. No. 10/971,575.
United States Patent and Trademark Office: Restriction Requirement dated Jan. 8, 2008, U.S. Appl. No. 10/971,576.
United States Patent and Trademark Office: Restriction Requirement dated Sep. 8, 2008, U.S. Appl. No. 11/837,484.
United States Patent and Trademark Office: Non-Final Office Action dated Mar. 20, 2009, U.S. Appl. No. 11/837,484.
Written Opinion of the International Searching Authority, PCT/US2004/035034, Jun. 28, 2005.
Written Opinon of the International Searching Authority, PCT/US2004/035289, Jun. 28, 2005.
Written Opinion of the International Searching Authority, PCT/US2004/034980, Mar. 10, 2005.
Gordon, C.J., “The Therapeutic Potential of Regulated Hypothermia,”Emerg. Med. J., 2001, 18, 81-89.
Gordon,E-Letter response to Science, 2005, retrievable at http://www.sciencemag.org/cg/eletters/308/5721/518, pp. 1-5.
Haouzi, P. et al., “H2S Induced Hypometabolism in Mice is Missing in Sedated Sheep,”Respiratory Physiology&Neurobiology, 2008, 160, 109-115.
Li, J. et al., “Effect of Inhaled Hydrogen Sulfide on Metabolic Responses in Anesthetized, Paralyzed, and Mechanically Ventilated Piglets,”Pediatric Critical Care Medicine, 2008, 9(1), 110-112.
Struv, M.F. et al., “Neurotoxicological Effects Associated with Short-Term Exposure of Sprague-Dawley Rats to Hydrogen Sulfide,”NeuroToxicology, 2001, 22, 375-385.
Wall, R.J. et al., “Are Animal Models as Good as We Think?”Theriogenology, 2008, 69, 2-9.
United States Patent and Trademark Office: Non-Final Office Action dated Sep. 28, 2009, U.S. Appl. No. 10/97
Fisher Abigail
Fred Hutchinson Cancer Research Center
Richter Johann R
Woodcock & Washburn LLP
LandOfFree
Methods, compositions and devices for inducing stasis in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods, compositions and devices for inducing stasis in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods, compositions and devices for inducing stasis in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2736705